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ABSTRACT
An analysis of the human chromosome 22 genomic
sequence shows that both Z-DNA forming regions
(ZDRs) and promoter sites for nuclear factor-I (NFI)
are correlated with the locations of known and predicted genes across the chromosome and accumulate around the transcriptional start sites of the known
genes. Thus, the occurrence of Z-DNA across human
genomic sequences mirrors that of a known eukaryotic transcription factor. In addition, 43 of the 383 fully
annotated chromosomal genes have ZDRs within 2
nucleosomes upstream of strong NFIs. This suggests
a distinct class of human genes that may potentially
be transcriptionally regulated by a mechanism that
couples Z-DNA with NFI activation, similar to the
mechanism previously elucidated for the human colony stimulation factor-I promoter [Liu et al. (2001)
Cell, 106, 309–318]. The results from this study will
facilitate the design of experimental studies to test
the generality of this mechanism for other genes in
the cell.

INTRODUCTION
The biological relevance of Z-DNA has been controversial
since its discovery in 1979 (1), with many of the early studies
raising as many questions as they answered (2). In recent
years, more rigorous studies have started to reveal specific
roles for Z-DNA in processes such as RNA editing (3,4).
One particularly interesting study of genes regulated by
BAF, the mammalian analogue of the yeast SWI/SNF switching complex, has resurrected the possible role of Z-DNA as a
transcriptional regulator when coupled with the nuclear factorI (NFI) or CAAT-box transcription factor (5). Here, we use a
computer-assisted approach to identify sites in human chromosome 22 that have the potential to form Z-DNA and that are
recognized as NFI promoter sites. This allows us to determine
whether Z-DNA coupled transcriptional-regulation may be
more general to a broader class of human genes.

Left-handed Z-DNA has been attributed to a variety of
biological functions in the cell [reviewed in (6)]. For many
years, claims of a biological role for Z-DNA were greeted with
great skepticism (2). Recently, however, the DNA binding
domains of double-stranded RNA adenosine deaminases
have been shown to bind specifically to Z-DNA (3,4,7,8).
The participation of Z-DNA in RNA processing is
consistent with the observation that Z-DNA can be induced
at the 50 ends of genes by transcription (9,10), and that potential Z-DNA forming sequences accumulate at and near the
transcriptional start sites (TSS) of human genes (11).
However, the large number of genes predicted to contain
potential Z-forming sequences (11) is inconsistent with
such a limited role.
Liu et al. (5) have recently revived the possibility that
Z-DNA may be an important component in the regulation
of certain mammalian genes. In their study, a DNA array
was used to screen a library of genes that are regulated by
the mammalian BAF complex. The screen identified 80
mRNA sequences whose levels are elevated and 2 that are
suppressed by the BAF complex. A detailed biochemical
analysis of the colony stimulating factor-I (CSF-1) gene, associated with one of the induced mRNAs, revealed a classic
Z-forming alternating CA/TG-repeat sequence immediately
upstream of the NFI consensus site. Replacing this CA/TGrepeat with a random sequence was seen to suppress the
activity of the CSF-1 promoter. Furthermore, this CA/TGrepeat was shown to be left-handed when the gene is actively
being transcribed. A model was proposed (Figure 1) in which
Z-DNA maintains the CSF-1 promoter in an activated state
(when coupled with the activity of a transcriptional activator)
by maintaining an open chromatin structure—it is well known
that Z-DNA does not bind to nucleosomes (12–15).
Here, we address the question of whether this mechanism
of coupling NFI activation with transcription-induced
Z-DNA may be unique to the CSF-1 gene or characteristic
of a larger class of similarly regulated genes. In the current
study, sequences that have strong thermodynamic potential to
form Z-DNA and to bind NFI were identified in human
chromosome 22 (16,17), a small genomic sequence with a
relative high density of genes. The results indicate that
a well-defined group of human genes may be regulated
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by coupling Z-DNA with a eukaryotic transcription
factor. Similar analyses of the Escherichia coli (E.coli)
genome (18) shows that this mechanism is not present in
prokaryotes.

METHODS
Sequence data
The sequence of chromosome 22 q-arm, release 3.1b (March 5,
2002), was retrieved as a single FASTA sequence from the
Sanger lab site (http://www.sanger.ac.uk/) (Table 1). The definitions of genes, pseudogenes and predicted genes (from
GENSCAN), along with start and end of each human gene,
were defined according to annotations in the Sanger site (complete as of March 25, 2003), with the direction and start site of
transcription determined by alignment of a gene sequence with
its associated mRNA or cDNA sequence. The sequence of the
E.coli strain K-12 was used as the representative prokaryotic
genome, and retrieved as a single file along with annotations
from the NCBI website (ftp.ncbi.nih.gov/genomes/Bacteria/
Escherichia_coli_K12/).
Defining Z-DNA regions (ZDRs)

Figure 1. Proposed mechanism for Z-DNA coupled transcriptional regulation
in BAF regulated genes (5). In this model, a nuclear factor I (NFI) consensus
sequence (yellow) in an inactive compact chromatin structure is first bound by
the transcription factor. The closed conformation of the chromatin is relaxed by
binding of the BAF complex and is further relaxed to the fully active open
conformation upon recruitment of RNA polymerase. Transcription of the
gene generates positive supercoils in front and negative supercoils behind
the polymerase in the topologically constrained chromatin fiber (22). The
negative supercoils induce a transition to left-handed Z-DNA in an
upstream region (red) (9), which maintains the chromatin in its activated
open conformation.

We had previously mapped Z-DNA in genes and genomes at
the base pair level using the program ZHUNT (11,19). Such a
detailed map in very large genomic DNAs, however, is burdensome; therefore, in the current study, contiguous nucleotides with strong potentials to form Z-DNA are grouped into
Z-DNA regions, or ZDRs. A ZDR is defined as a set of contiguous base pairs with Z-DNA propensities (PZ) that are
greater than or equal to a predefined lower limit (PZmin).
The parameter PZ is defined here, called the ‘Z-score’ in
earlier versions of ZHUNT (11,19), as the number of random
base pairs that must be searched to find a sequence that is as
good or better at forming Z-DNA as the sequence being analyzed. PZ, therefore, is a statistical test for the uniqueness of a
sequence. Here, we have recalculated this parameter to reflect
the proper distribution of the probabilities for any sequence
within the context of 33 million random nucleotides; therefore
PZ is now more accurately defined, and is distinguished from
the true statistical ‘z-score’, which is calculated differently. In
searching through long genomic sequences, a new ZDR is
started with a base pair in which PZ > PZmin and is terminated
with any base pair in which PZ < PZmin. The minimum size of a
ZDR is 12 bp, or one full turn of Z-DNA.
We set the value for PZmin = 0.5 kb. This corresponds to a
contiguous stretch of alternating CA/TG 12 bp in length,
which has been shown experimentally to adopt Z-DNA
under reasonable levels of negative superhelical densities
(20), and conforms to our definition of a minimum Z-forming
sequence in previous studies (11,19). The archetypical Z-DNA

Table 1. Occurrence of ZDRs in human chromosome 22 (16,17) and the E.coli genome (18)
Sequence type
Chromosome 22
Genes
Pseudogenes
Predicted genes
E.coli genome
Genes
a

Number

383
234
790
4279

Number of bp
33 821 688
15 671 983
837 815
22 887 969
4 639 262
4 098 295

Number of sequences
w/ZDRs

% Sequences
w/ZDRs

370
100
687

96.6%
42.7%
87.0%

3597

82.7%

Total number
of ZDRs

Expected #
ZDRsa

7580
4009b
313b
5969b
3500
3497

(48 317)
3684
293
5484
(6627)
3092

Number of ZDRs predicted for a sequence (in parentheses) was calculated by taking the total number of base pair in that sequence and dividing by Pmin (500 bp). The
predictions for how the observed ZDRs are distributed between genes, pseudogenes and predicted genes are based on the 7580 actually observed in chromosome 22
multiplied by the fraction of the total sequence represented by that sequence type.
b
ZDRs that appear in two different overlapping gene, pseudogene and/or predicted gene sequences are counted for both sequences.
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sequence of 24 bp, d(CG)12 has the highest possible PZ value
(4.1 · 108); there are, however, no alternating d(CG) of
such length in this chromosomal sequence. A simple sequence search for this motif therefore could not constitute a
comprehensive search for the occurrence of the left-handed
conformation.
Defining potential binding sites for the NFI
transcription factor
NFI recognizes the consensus inverted repeat sequence
TTGGCN5GCCAA, where N5 is a spacer of any 5 nt. Roulet
et al. (21) have systematically determined the effect on NFI
binding of modifying any nucleotide and the spacer length
within this consensus sequence. The resulting set of binding
scores can thus be used to predict the relative binding affinities
for NFI (Figure 2a). The actual variations in these NFI binding
scores, however, are small. Even the known NFI promoter
sequence in, for example, the CSF-1 gene (5) does not distinguish itself above the noise. In order to define a propensity for
binding that is analogous and thus comparable to the propensities for Z-DNA formation (PZ), we have applied a statistical
test for the occurrence of all possible variations of the NFI
consensus sequence.
We have defined a propensity for a sequence to bind NFI
(PNFI) in a manner analogous to PZ, where PNFI is the number
of random sequences that must be searched to find a site that
has the same or higher affinity for the transcription factor.
For this parameter, we first calculated the NFI binding scores
for all possible variations of the consensus full and half sites.
This allowed us to define explicitly the frequency and thus
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uniqueness of every possible NFI binding score as defined by
Roulet et al. (21). In the case of the CSF-1 gene (Figure 2b),
the known NFI promoter stands-out with a PNFI  1.2 · 105 bp
(equivalent to a raw binding score of 98), which reflects the
uniqueness of this sequence. We should note that PNFI values
mirror the affinity constant KA, except for the magnitude of the
values (PNFI values are 2000 times smaller than the comparable KA). Thus, PNFI calculated in this manner provides a
conceptual link between the affinity and the uniqueness of any
particular nuclear transcription factor recognition site.
With the PNFI values, we defined criteria to help distinguish
functional from nonfunctional NFI sites. It is clear that binding
affinity is not the sole determinant of activity, since a sequence
with a binding score of 80 can show greater activation than one
with a score of 84 (21). If we assume that the function of NFI
as a eukaryotic transcription factor should distinguish itself in
human sequences, then we should see a distinction between
the occurrence of NFI sites between chromosome 22 and a
similar random sequence. For this analysis, we generated a
random sequence with the same length and G + C content as
that of human chromosome 22, and mapped the location of
genes from the chromosome onto this random sequence. We
then analyzed the human and random sequences for NFI sites
within the defined gene regions for various values of PNFImin
and with various lengths of sequence added to both sides of the
TSS of each gene. The differences between the number of NFIs
located at the gene positions of the random chromosome
sequence and those of identified genes in the actual chromosomal sequence are plotted for each PNFI value (Figure 3a).
From this analysis, we see that the human sequences become
distinct from random (difference > 0) for PNFI values >0.5 kb

Figure 2. Prediction of NFI and ZDRs in the human CSF-1 gene. (a) Binding scores as defined by Roulet et al. (21). The binding scores are calculated according to
values assigned to each nucleotide position and linker length (n), with the maximum score = 100 for the NFI consensus sequence. The best score was calculated
starting with each nucleotide of the CSF-1 gene, including 1 kb of sequence upstream of the transcriptional start site (TSS) and 2 kb downstream of the 30 -terminus.
(b) Comparison of the statistical uniqueness (PNFI) and association constant (KA) for NFI sites, and locations of ZDRs. Binding scores for each nucleotide are
converted to PNFI values (in kb) from A, as described in Methods, and compared to the analogous KA values. The locations of ZDRs along the gene, as predicted by
ZHUNT, are shown as bars.

6504

Nucleic Acids Research, 2004, Vol. 32, No. 22

(a)

(b)

(c)

Figure 3. Classification of ZDRs and NFI sites. (a) The percentage of gene
sequences with NFI sites located in chromosome 22 and in a random sequence
with the same length and C + G content as this chromosome (with gene locations
mapped from the chromosomal sequence) are subtracted and compared to the
raw binding scores of Roulet et al. (21) (x-axis). The chromosomal genes
deviate from the random sequence at scores >65 (or at PNFI > 0.5 kb), and
show the greatest deviation from random at NFI binding scores of 87. Binding
scores at the inflection point for the curve (>80, or equivalent to PNFI > 5 kb)
define a class of strong and potentially functional NFI sites. Sequences with
binding scores between 65 and 80 (0.5 kb < PNFI < 5 kb) define the nonrandom
but weak binding NFI sites. (b) The percentage difference in the number of
ZDRs and NFI sites located in human chromosome 22 relative to random DNA
with overall C + G content identical to that of the chromosomal sequence. The
x-axis shows an increasing number of supercoils required to induce Z-DNA
( j DLkZ-DNA j , associated with increasingly poor Z-DNA forming sequences),
while the y-axis are the NFI scores calculated using the values reported by
Roulet et al. (21). (c) The percentage difference in the number of ZDRs and NFI
sites located in human chromosome 22 and a random sequence with the
identical C + G distribution across the sequence as the chromosome.

(or a raw binding score of 65), with the largest deviation from
random occurring at PNFI  20 kb (raw score of 86). We have
defined PNFI  5 kb (raw score of 80), midway between random and highly nonrandom, to distinguish a class of strong
and potentially functional NFI sites. In comparison, there was
no difference seen for NFI sites located in E.coli genes as
compared to the associated random sequences, indicating
that, as expected, eukaryotic transcription factor consensus
sequences are located randomly in a prokaryotic genome.
We therefore have classified NFI sites as random PNFI
values <0.5 kb, nonrandom and weak PNFI values between
0.5 and 5 kb, and strong PNFI values >5 kb, and will use these
classifications for the remainder of this paper. These definitions are consistent with the functional activities reported for
NFI promoter sites (21). Sequences that are categorized as
nonrandom and weak include those that show 10% of the
activity seen with a consensus NFI sequence in a luciferase
assay, but significantly above background, while those categorized as strong and potentially functional exhibit at least
25% of the activity compared to the consensus sequence.
Finally, all but one of the 37 annotated genes identified as
BAF regulated (5) have at least one NFI site identified with
PNFI > 0.5 kb.
To test for the accuracy of the predictions for promoter
binding, we located 28 genes where there is good experimental
evidence for protein binding at an NFI promoter or its variant
(www.gene-regulation.com). Of these, 26 (92.9%) were found
by our program to have sites with raw binding scores >65
(PNFI > 0.5 kb, our definition for a nonrandom sequence)
within 1 kb of the identified TSS, and 10 of these had
scores >80 (defined here as being functional) (Supplementary
Table 1). In contrast, it is almost impossible to test for false
positives for this class of transcriptional factors. The most
definitive test would be to apply the program towards genes
that are known to not bind NFI protein; however, no such
dataset exists to our knowledge. For example, many genes
with active cis-regulatory elements will also have an NFI/
CTF binding site, and may be either positively or negatively
regulated by these sites. Thus, we cannot simply assemble a
dataset of genes that are known to be regulated by a promoter
other than NFI, since there is no experimental evidence that
such genes do not also include functional NFI binding sites.
Thus, although we are very confident that the cutoffs defined
here are sufficient to include nearly all genes known to bind the
NFI protein, we cannot make any accurate estimates for the
number of genes predicted to have an NFI binding site that
does not bind protein in the cell.

RESULTS
In this study, we address the question of whether there is any
relationship between NFI activation and the occurrence of
Z-DNA in human genes. The sequence of human chromosome
22 was analyzed using the statistical thermodynamic treatment
for Z-DNA implemented in the ZHUNT program (11,19),
which was previously shown to accurately predict sequences
with strong potential to adopt the left-handed conformation,
and an analogous statistical method based on the affinity constants (21) used to search for potential NFI binding sites.
Applying thermodynamic strategies to identify potentially
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functional sequences has both advantages and disadvantages.
The advantage is that there is no need for training sets. If we
accept, for example, that the affinity of a nuclear factor for a
particular site plays a major role in transcriptional regulation,
then a search for all sites with affinity constants that allow
for recognition and binding should yield a list of all DNA
sequences that could serve as potential promoter sites. The
disadvantage, of course, is that we need to define what are
considered to be strong or relevant affinity constants, and we
do not consider other factors (such as interactions with accessory proteins) in the thermodynamic model that may be important for defining a functional promoter. In the current study, we
use the thermodynamic algorithm in ZHUNT to identify
potential Z-DNA forming sequences (ZDRs). The algorithm
in ZHUNT had previously been shown to accurately define not
only the location at the nucleotide level, but also the relative
propensity of sequences in genomes to adopt the left-handed
Z-conformation (19). The actual formation of Z-DNA in these
sequences in the cell requires introduction of negative supercoiling (e.g. during chromatin remodeling) and, therefore, we
should recognize that the potential ZDRs will become lefthanded only under specific circumstances, which are not
entirely well understood and which we do not attempt to predict here. Similarly, for the NFI sites, promoters are defined by
many criteria other than affinity of a protein for a sequence.
Thus, although our general definitions follow the functional
luciferase assay results as originally reported by Roulet et al.
(21), we should again qualify the search results by indicating
that these are all potential promoter sites.
We can ask how the cut-off values of the two sequence types
(ZDRs and NFI sites) correspond to what one would expect
around the TSS of genes. Figure 3b compares the occurrence
of ZDRs and NFI sites at various values of superhelical density
(DLk) required to induce a ZDR to become left-handed (as
predicted from ZHUNT) and the raw binding scores for NFI
recognition of sites for sequences 1000 bp upstream and downstream of the TSS for the annotated genes of chromosome 22
relative to a random chromosome. In this analysis, the random
chromosome is generated with the same length and overall
average C + G content as the human sequence, with the locations of the transcriptional start and end sites, and direction of
transcription mapped onto this random sequence. This comparison shows that for the PZmin > 500 bp (DLk > 22 supercoils), the number of ZDRs located is significantly higher (up
to 30% greater) than expected in the random sequence. Similarly, for NFI scores >60, the number of potential promoter
binding sites is greater than in the random sequence. At very
high values of PZmin and NFI scores, what is observed in the
human genes approaches what is expected for the random
sequence, probably because of the very small numbers of
sequences one would expect.
If we take the C + G content in and around the TSS into
account (generating random sequences with the same distributions of C + G content at each position either upstream or
downstream of the TSS), the numbers of ZDRs is again nonrandom, but becomes lower than expected. For potential NFI
binding sites, there are apparently two sets of nonrandom
groups of sequences, one between scores of 60 and 80 and
the other with NFI scores >80. Thus the nonrandom behaviour
of the ZDRs for PZmin > 500 bp is consistent with what we had
expected from the types of sequences that can reasonably form
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Z-DNA. In addition, the two classes of nonrandomly behaving
NFI type sequences with binding scores from 65 to 80 and
>80, which we define as nonrandom and strong potential NFI
sites, respectively, are consistent with what was reported in
terms of the effect of such sequences on gene activation
according to a luciferase assay.
Although ZHUNT had previously been applied to a limited
set of human genes, the current analysis allows us to identify
ZDRs in various functional sequence classes in a complete
chromosome. The corresponding analysis for potential NFI
sites reveals the proportion of genes in chromosome 22 that
are potentially regulated by this nuclear transcription factor.
Finally, comparing the results of the two analyses allow us to
answer the question of whether Z-DNA is associated with a
particular class of regulated genes and, thus, plays a general
function in the regulation of transcription for a distinct group of
human genes. With the qualifications stated above, the list of
gene sequences that result from this analysis should be interpreted as being a starting point to help the experimentalist
design studies to determine whether a particular gene actually
utilizes such a coupled mechanism of transcriptional regulation.
Occurrence of NFIs and ZDRs in human
chromosome 22 and the E.coli genome
There are a very large number of NFI sites in the nonrandom
and functional classes identified in the human chromosome 22
sequence (Table 2), slightly higher than expected from random. In addition, nearly every sequence identified and predicted as a potential gene in human chromosome 22 was found
to contain at least one NFI sequence in the functional class.
The distribution of these sites across the human chromosome
(Figure 4), however, is nonuniform, and appears to correlate
with the distribution of known and predicted genes (R = 0.65
for the functional and 0.71 for the nonrandom class of NFIs to
the combined annotated and GENSCAN predicted genes).
Thus, there is a distinct distribution of the eukaryotic transcription factor in the human sequence, as one would expect.
Furthermore, we see that it is not simply the occurrence of
binding sites, but their distribution that define the function of
NFI as a transcriptional activator.
Using a value for PZmin = 0.5 kb, we have located 7580
ZDRs in human chromosome 22, representing 0.454% of the
known sequence (Table 1), or that there is one ZDR in
4462 bp. Overall, the number of ZDRs in chromosome 22
is lower than predicted from random occurrence (for a
PZmin = 0.5 kb) by >6-fold. The distribution of observed
ZDRs into genes, pseudogenes and predicted genes are essentially what one would expect from random occurrence when
considering the percent of the chromosome sequence represented by each sequence type (Table 1). In contrast, the number of genes, pseudogenes and predicted genes that contain
ZDRs differ, with nearly all known genes (96.6%) and predicted genes (87%) having at least one ZDR, while fewer than
half (42.7%) of the pseudogenes contain ZDRs. It is interesting
at this point to see that the number of gene sequences with
ZDRs at or near the TSS is 77% of the total, while those with
ZDRs at the 30 end is only approximately one-third (33.4%).
This discrepancy between the two ends of the sequences is
most dramatic for the annotated genes, but is also seen for
pseudogenes and predicted genes. Thus, unlike the NFIs, ZDRs
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Table 2. Occurrence of NFI binding sites predicted in human chromosome 22 (16,17)
Sequence type

Chromosome 22
Genes
Pseudogenes
Predicted genes

Number of sequences w/NFIs (%)
Nonrandomb
Total
(500 > PNFI > 5000)
(PNFI > 500)

Strongb
(PNFI > 5000)

Total number of NFIs (predicteda)
Total
Nonrandomb
(PNFI > 500)
(500 > PNFI > 5000)

Strongb
(PNFI > 5000)

383 (100%)
234 (100%)
790 (100%)

373 (97.4%)
139 (59.4%)
730 (92.4%)

90777 (70 905)
45619b (34 461)
3514b (2737)
67371b (51 295)

9818 (6225)
5022b (3025)
393b (240)
7526b (4504)

383 (100%)
233 (97.6%)
788 (99.8%)

80959 (64 680)
40597b (31 461)
3121b (2497)
59845b (46 792)

a
Numbers of NFI binding sites predicted for genes, pseudogenes and predicted genes are based on the actual number of sites observed multiplied by the fraction of the
total number of base pairs represented by that sequence type.
b
NFI sites that appear in two different overlapping gene, pseudogene and/or predicted gene sequences are counted for both sequences.

Figure 4. Distribution of genes (a), GENSCAN predicted genes (b), NFI sites (c) and ZDRs (d) along the human chromosome 22 sequence. The occurrence of each
sequence type is summed for each 1% increment of the chromosomal sequence.
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are much less frequent and, when they do occur, tend to be
more discriminate in location.
The distribution of ZDRs across chromosome 22 very
closely mirrors that of NFIs (Figure 4d), with correlation
between the number of nonrandom NFIs and ZDRs across
the chromosome giving an R-value of 0.72 (Figure 5).
There is no a priori reason why NFIs and ZDRs should be
correlated. Sequences that are strong NFIs do not show an
alternating purine–pyrimidine pattern and are not necessarily
rich in CG base pairs; therefore, they should be very weak
ZDRs (sequences in the functional class of NFI sites, with
PNFI > 5 kb, have PZ at least one order of magnitude
lower than the PZmin of 0.5 kb used to identify ZDRs). The
correlation between ZDRs and the predicted and known
genes across the chromosome (R = 0.59) is not as strong as
that seen for NFIs. However, applying a Spearman Rank
Correlation test indicates that the probability of having no
correlation between the distributions of ZDRs and the
known genes is <7 in 10 000 ( p-value = 0.0007), and <1 in
10 000 ( p-value = 0.0001) against the predicted genes.
Distribution of NFIs and ZDRs around the gene
termini
Both NFI and ZDR sequences accumulate around the known
TSS of the human genes. The number of nonrandom NFIs
(PNFI > 0.5 kb) rises above background levels from 1 kb
upstream to 1 kb downstream of the TSS (a similar, but less
pronounced distribution is seen for the functional class of
NFIs) and has a maximum count at 140 bp downstream
of the TSS (Figure 6). At the 30 terminus of these known
genes, the number of NFIs shows a very distinct dip. Thus,
the distributions of NFIs across the known genes in chromosome 22 correlate with the known function of these sites,
accumulating around the 50 end, and suppressed where specific
sequence signals are required for transcription termination.
We had previously seen in a more limited study (11) that
ZDRs accumulate at the TSS of human genes. In the current
study, we observe that 295 of the 383 identified genes (or
>77%) in chromosome 22 have ZDRs within –1 kb of the
TSS. The larger sample size in the current study reveals a
defined distribution of ZDRs centered upstream of the TSS
by 40 bp (and upstream of the NFI distribution by 180 bp)
and extending 1 kb in either direction (Figure 6b). At the 30
termini, ZDRs are distributed apparently randomly, but we
should note that the very small number of ZDRs in this region
does not allow us to determine whether such sequences are
suppressed at this end. Thus, we see a strong correlation
between the distribution of ZDRs and NFIs across human
genes, with ZDRs accumulating upstream of both NFI and
TSS loci.
This accumulation of NFIs and ZDRs around the TSS of the
human genes follows the distributions of C/G base pairs
(%C + G content, Figure 6c) and d(CpG) dinucleotides
(data not shown). One can argue that the accumulation of
the ZDRs is the direct consequence of the C/G content around
the TSS. However, the majority of the ZDRs in chromosome
22 are CA/TG type sequences (which are only 50% C + G). In
addition, we see that C + G nucleotides are distributed broadly
both upstream and downstream of the TSS, while ZDRs are
biased upstream and NFIs downstream of the TSS. Thus, we
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Figure 5. Correlation between the distribution of NFI and ZDR sites across
human chromosome 22. The values from Figure 4 for NFIs (4c) and ZDRs (4d)
are plotted against each other. The line is a linear least squares fit with R = 0.72.

suggest that it is not simply the C + G content that determines
the accumulation of ZDRs around the TSS. Indeed, it is possible to argue the opposite point that the C + G distribution is a
consequence of the distribution of ZDR and NFI (and potentially other high C/G content transcriptional elements), given
that the C + G distribution appears to mirror the sum of the
ZDR and NFI distributions, but neither in themselves. For
example, although we would expect TATA promoters to be
favored in T + A rich regions upstream of a TSS, we would
conclude that it is the localization of the promoters that defines
the distribution of the nucleotide content and not vice versa. In
support of this latter point for the current study, we see that the
residual difference between the normalized ZDR and C + G
distributions around the TSS of genes is a broad distribution
with a maximum 200 bp downstream of the TSS, similar
overall to the distribution of NFI sites.
With the strong preference of Z-DNA for alternating CG
dinucleotides, one can ask whether the occurrence of ZDRs
seen here correlates with CpG islands. We observed that with a
PZmin > 0.5 kb, only 9.3% of the ZDRs in chromosome 22 fell
into known CpG islands (identified at ftp://ftp.ncbi.nih.gov/
genomes/H_sapiens/maps/mapview/BUILD.34.3/). A higher
percentage of ZDRs located within 1 kb of the TSS are within
CpG islands (28.2%), reflecting the preference of both motifs
upstream of genes. However, it is clear from this analysis that
the ZDRs identified in this study do not simply mirror CpG
islands. This is consistent with the large number of ZDRs that
are primarily alternating CA/TG repeats.
Similarly, only 9.2% of the identified NFI binding sites
across human chromosome 22 fall into known CpG islands.
Again, this increases to 28.3% for NFI sites identified –1 kb of
the TSS of known genes. It is clear, therefore, that neither the
ZDR and NFI sites identified here are the direct result of the
localization of CpG islands upstream of the initiation sites for
transcription in these genes.
Interestingly, the distributions of NFIs and ZDRs across
predicted genes mirror that seen in the known genes, but
only for those sequences predicted by GENSCAN to have
introns (data not shown). These distributions are significantly
suppressed, or flat for GENSCAN sequences that lack introns.
Finally, the analysis of E.coli genes shows that ZDRs and NFIs
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Figure 7. Distribution of NFIs (a), ZDRs (b) and the C + G content (c) around
the transcription start sites (TSS) and 30 terminus of genes in the E.coli genome.
The genes are aligned with their TSS or 30 ends (arrows), and the number of each
sequence type are summed in 200 bp increments, starting 1 kb upstream and
extending 1 kb downstream of both the TSS and 30 ends of the aligned genes.

DISCUSSION
Figure 6. Distribution of NFIs (a), ZDRs (b), and the C + G content (c) around
the transcription start sites (TSS) and 30 terminus of known genes in human
chromosome 22. The genes in the chromosomal sequence are aligned with their
TSS or 30 ends (arrows), and the number of each sequence type are summed in
200 bp increments, starting 2 kb upstream and extending 2 kb downstream of
both the TSS and 30 ends of the aligned genes. Values for the 30 ends for the NFI
and percent C + G are offset from the TSS distributions to fit into the panels.
(d) Comparison of numbers of ZDRs with C + G content around the TSS of
human genes. The upper figure shows an overlay of (b) and (c), assuming that a
1% increase in C + G content is associated with an increased probability of
seeing one ZDR. The lower panel shows the residual resulting from subtracting
the two distributions. (e) Comparison of the residual from (d), bottom figure, to
the distribution of potential NFIs (a) around the human TSS, top figure.

are strongly suppressed at both the TSS and the 30 end,
reflecting the incompatibility of well-defined transcription
promoter, initiation and termination sites in prokaryotic
genes with both the eukaryotic promoter and ZDRs (Figure 7).

In this study, we have applied an in silico approach to identify
potential Z-DNA regions (ZDRs) and binding sites for the NFI
transcription factor in the human chromosome 22 sequence
(16,17). The distribution of ZDRs across the genomic sequence and at the transcriptional start sites of genes, remarkably, is nearly identical to those of NFI sites; thus, if we were
to classify regulatory elements according to their genomic
distributions, the behavior of ZDRs could be considered to
be similar to that of a eukaryotic nuclear factor binding site.
The primary question that we addressed in the current study is
whether the mechanism of Z-DNA coupled transcription regulation, as characterized in the CSF-1 gene by Liu et al. (5), is
common to a set of human genes. In this mechanism, lefthanded Z-DNA serves to maintain a gene in its activated state
after initial activation by the BAF and NFI complexes. It has
been shown that Z-DNA does not bind to nucleosomal proteins
(12–15) and, therefore, would inhibit the reestablishment of a
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Table 3. Number of genes with strong (PNFI > 5 kb) NFI binding sites that also have ZDRs, both within 1 kb of their transcriptional start sites (TSS)
BAF regulated genes [37 annotated of 82 total (5)]
Total
ZDR upstream (bp)
ZDR downstream (bp)
11

<150
150–300
>300

3
1
2

<150
150–300
>300

3
1
1

Chromosome 22 genes [383 annotated (16,17)]
Total
ZDR upstream (bp)
ZDR downstream (bp)
156

<150
150–300
>300

26
17
27

<150
150–300
>300

36
17
33

Listed are the total number of sequences with NFIs and ZDRs in the BAF regulated genes (5) and identified in human chromosome 22, along with the number of
sequences with ZDRs that are <150 bp, between 150 and 300 bp, and >300 bp upstream or downstream of the strongest NFIs in each group.

stable chromatin structure. The formation of Z-DNA would be
induced by the negative superhelices generated behind an
active RNA polymerase, as originally proposed in the twindomain model (22). This is consistent with the observation
made previously (11), and more definitively demonstrated
here, that Z-DNA elements accumulate near the TSS of
human genes. In addition, it has been shown that the
Z-DNA binding domain from ADAR1 can in itself act as a
cis-regulatory element in yeast (23).
For the current analysis, we first characterized the ZDR and
NFI sites for the sequences identified as being affected by the
BAF complex (5). Of the 80 mRNAs that were observed to be
BAF regulated, only 37 are associated with fully annotated
gene sequences at the time of this study. All but one of these
known genes contained at least one functional NFI site with
PNFI > 5 kb and within –1 kb of the TSS. This is not surprising
since the NFI promoter is expected to be one of the common
elements in these BAF regulated genes. Of these, 11 (30% of
the 37) also have ZDRs within 1 kb of the TSS (Table 3).
We can conclude therefore that nearly one-third of the
genes associated with BAF regulation may potentially
involve Z–DNA in a manner analogous to that of the
CSF-1 gene.
For the annotated gene sequences in human chromosome
22, 370 (97%) have nonrandom NFI sites and 295 have
ZDRs within –1 kb of their TSS (Table 3). Of these, 158
sequences contain both potentially functional NFI and ZDR
sites within 1 kb of the TSS. Thus, if the mechanism for
Z-DNA and NFI activation in the BAF regulated genes is
general, we would predict that 41% of the genes in
human chromosome 22 could potentially be similarly
regulated.
The model that couples Z-DNA to BAF-regulation of
human genes as proposed by Liu et al. (5), however, may
impose additional constraints to the architecture of promoter
elements within this class of gene sequences. For example, in
order to maintain an activated gene-state, there may be the
additional requirement that Z-DNA elements also be upstream
of the NFI binding sites so that the spatial orientation of the
promoter and TSS are not adversely affected by the transcriptionally induced left-handed double helix. It may also be necessary to place the Z-DNA elements within one or two
nucleosome distances (100–300 bp) from the NFI site so
that it is the nucleosome structure at or near the activation
site that is affected by the structural transition. For the gene
sequences identified by Liu et al. (5) and in chromosome 22,
near equal numbers of sequences have their closest ZDRs
upstream and downstream of the strongest NFIs (Table 3).
However, ZDRs associated with NFI sites that are upstream
of the TSS are also twice as likely to be upstream of the NFI

site. Similarly, ZDRs are twice as likely to be downstream of
the NFI site if the promoter sequence is also downstream of the
TSS. Thus, under these constraints, we would predict that 44
genes (11%) of the annotated genes in chromosome 22 may be
regulated by a mechanism similar to that for CSF-1, with their
ZDRs located within 300 nt upstream of a strong NFI site. The
large number of sequences that have Z-DNA sites downstream
of the NFI sites suggests a separate class of genes that may
be regulated through a variation on this coupled mechanism,
with the transcriptionally driven formation of Z-DNA serving
to attenuate the rates of gene expression (11). The possibility
of this negative mechanism of gene regulation by the Z-form
of DNA has yet to be experimentally explored in detail.
However, it has been shown that Z-DNA placed near the
TSS of some genes will inhibit rather than enhance gene
expression (24,25).
The mechanism of Z-DNA coupled transcriptional activation may be general and extend beyond the NFI class of promoters. For example, Wang et al. (26) reported that a Z-DNA
forming segment at the proximal core promoter of the mouse
MARCKS promoter is important for basal transcription. Thus,
the regulation of transcription by eukaryotic promoters is not
dependent solely on the binding properties of the protein to the
cognate DNA, but the dynamic nature of the DNA doublehelix now appears to play an important role in maintaining an
activated state. Obviously, the predictions for such regulation
of specific genes need to be tested experimentally to confirm
their mechanism of regulation. For example, formation of
Z-DNA within these upstream sequences would require release of negative superhelical density resulting from dramatic
remodeling of the chromatin structure (which may be the link
to BAF regulation). In the absence of this superhelical energy,
the potential ZDRs would likely remain in their standard righthanded conformation and, therefore, would not participate in
the regulatory mechanism. Thus, additional work must be
done to determine whether such topological strain can be
induced for the individual genes. In addition, we recognize
that other accessory protein factors would need to be incorporated into the thermodynamic model in order to increase our
confidence in identifying functional promoters at the potential
NFI sites identified here. This can be explored further as we
survey genomic sequences for other transcription-factor binding sites and correlate them to various architectural DNA
elements such as Z-DNA.

SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online.
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